- Home
- WASH vs ORIC Comparison
WASH vs ORIC Comparison
Compare WASH & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WASH
- ORIC
- Stock Information
- Founded
- WASH 1800
- ORIC 2014
- Country
- WASH United States
- ORIC United States
- Employees
- WASH N/A
- ORIC N/A
- Industry
- WASH Major Banks
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- WASH Finance
- ORIC Health Care
- Exchange
- WASH Nasdaq
- ORIC Nasdaq
- Market Cap
- WASH 623.4M
- ORIC 735.3M
- IPO Year
- WASH N/A
- ORIC 2020
- Fundamental
- Price
- WASH $32.52
- ORIC $10.84
- Analyst Decision
- WASH Hold
- ORIC Strong Buy
- Analyst Count
- WASH 2
- ORIC 9
- Target Price
- WASH $34.00
- ORIC $18.75
- AVG Volume (30 Days)
- WASH 205.0K
- ORIC 825.1K
- Earning Date
- WASH 01-29-2025
- ORIC 03-10-2025
- Dividend Yield
- WASH 6.78%
- ORIC N/A
- EPS Growth
- WASH N/A
- ORIC N/A
- EPS
- WASH N/A
- ORIC N/A
- Revenue
- WASH $98,251,000.00
- ORIC N/A
- Revenue This Year
- WASH N/A
- ORIC N/A
- Revenue Next Year
- WASH $10.09
- ORIC N/A
- P/E Ratio
- WASH N/A
- ORIC N/A
- Revenue Growth
- WASH N/A
- ORIC N/A
- 52 Week Low
- WASH $24.11
- ORIC $6.33
- 52 Week High
- WASH $40.59
- ORIC $16.65
- Technical
- Relative Strength Index (RSI)
- WASH 48.04
- ORIC 52.90
- Support Level
- WASH $30.79
- ORIC $9.92
- Resistance Level
- WASH $32.89
- ORIC $12.00
- Average True Range (ATR)
- WASH 0.99
- ORIC 0.90
- MACD
- WASH 0.19
- ORIC 0.04
- Stochastic Oscillator
- WASH 57.22
- ORIC 41.82
About WASH Washington Trust Bancorp Inc.
Washington Trust Bancorp Inc through its subsidiaries offers banking and financial services to individuals and businesses. It operates in two segments. The Commercial Banking segment includes lending activities, commercial loans, residential real estate loan deposit activities, and others. The Wealth Management Services segment consists of investment management, financial planning, personal trust, and estate services including services as trustee, personal representative, custodian and guardian, and settlement of decedents' estates. The bank generates a majority of its revenue from the Commercial Banking segment.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.